The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 15 results:
Author Title [ Type(Desc)] Year
Filters: Keyword is Immunoglobulins, Intravenous  [Clear All Filters]
Journal Article
Metallidis, S., Papaioannou M., Bokolas G., Kollaras P., Gogou V., & Nikolaidis P. (2009).  Acute renal failure following intravenous immunoglobulin therapy in a HIV-infected patient.. Clin Nephrol. 71(2), 196-7.
Mantadakis, E., Farmaki E., Thomaidis S., Tsalkidis A., & Chatzimichael A. (2010).  A case of immune thrombocytopenic purpura after influenza vaccination: consequence or coincidence?. J Pediatr Hematol Oncol. 32(6), e227-9.
Gogou, M., Papadopoulou-Alataki E., Spilioti M., Alataki S., & Evangeliou A. (2017).  Clinical Applications of Intravenous Immunoglobulins in Child Neurology.. Curr Pharm Biotechnol. 18(8), 628-637.
Gathmann, B., Mahlaoui N., Gérard L., Oksenhendler E., Warnatz K., Schulze I., et al. (2014).  Clinical picture and treatment of 2212 patients with common variable immunodeficiency.. J Allergy Clin Immunol. 134(1), 116-26.
Trappe, R., Riess H., Anagnostopoulos I., Neuhaus R., Gärtner B. C., Pohl H., et al. (2009).  Efficiency of antiviral therapy plus IVIG in a case of primary EBV infection associated PTLD refractory to rituximab, chemotherapy, and antiviral therapy alone.. Ann Hematol. 88(2), 167-72.
Gathmann, B., Grimbacher B., Beauté J., Dudoit Y., Mahlaoui N., Fischer A., et al. (2009).  The European internet-based patient and research database for primary immunodeficiencies: results 2006-2008.. Clin Exp Immunol. 157 Suppl 1, 3-11.
Tselios, K., Klonizakis P., Sarantopoulos A., Gkougkourelas I., & Boura P. (2013).  Fatal refractory thrombotic thrombocytopenic purpura complicating systemic lupus erythematosus.. J Clin Rheumatol. 19(7), 412-4.
Papagianni, A., Economou M., Tragiannidis A., Karatza E., Samarah F., Gombakis N., et al. (2013).  FcγRIIa and FcγRIIIa polymorphisms in childhood primary immune thrombocytopenia: implications for disease pathogenesis and outcome.. Blood Coagul Fibrinolysis. 24(1), 35-9.
Behlivani, E., Tragiannidis A., Hatzipantelis E., & Panagopoulou P. (2021).  Immune thrombocytopenia secondary to COVID-19 infection:  Report of two cases.. Pediatr Blood Cancer. 68(10), e29175.
Tselios, K., Sarantopoulos A., Gkougkourelas I., & Boura P. (2015).  The influence of therapy on CD4+CD25(high)FOXP3+ regulatory T cells in systemic lupus erythematosus patients: a prospective study.. Scand J Rheumatol. 44(1), 29-35.
Molife, L. R., Fong P. C., Paccagnella L., Reid A. H. M., Shaw H. M., Vidal L., et al. (2010).  The insulin-like growth factor-I receptor inhibitor figitumumab (CP-751,871) in combination with docetaxel in patients with advanced solid tumours: results of a phase Ib dose-escalation, open-label study.. Br J Cancer. 103(3), 332-9.
Pyrpasopoulou, A., Athyros V. G., Karagiannis A., Chrysomallis F., & Zamboulis C. (2007).  Intravenous immunoglobulins: a valuable asset in the treatment of a case of septic febrile ulceronecrotic Mucha-Habermann disease.. Dermatology. 215(2), 164-5.
Lamari, F., Karamanos N. K., Papadopoulou-Alataki E., Kanakoudi-Tsakalidou F., Dimitracopoulos G., & Anastassiou E. D. (2000).  Monitoring of two intravenous immunoglobulin. Preparations for immunoglobulin G subclasses and specific antibodies to bacterial surface antigens and relation with their levels in treated immunodeficient patients.. J Pharm Biomed Anal. 22(6), 1029-36.
Ioannidis, P., Parissis D., Karapanayiotides T., Maiovis P., Karacostas D., & Grigoriadis N. (2015).  Spinal cord involvement in chronic inflammatory demyelinating polyradiculoneuropathy: a clinical and MRI study.. Acta Neurol Belg. 115(2), 141-5.
Soldatou, A., Vartzelis G., Vorre S., Papa A., Voudris K., & Garoufi A. (2013).  A toddler with acute flaccid paralysis due to West Nile virus infection.. Pediatr Infect Dis J. 32(9), 1023-4.

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.